pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
BEAM-302
Alpha-1 Antitrypsin Deficiency (A1AD)
$BEAMBeam Therapeutics Inc.
0 catalysts
Phase 2
BGB-16673
Refractory Chronic Lymphocytic Leukemia (CLL)
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 2
BGC-101
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
BiogenCell Ltd
0 catalysts
Phase 2
← prev
page 7 of 50
next →
131
Pain89
Neurology1
BHV-1510
Solid Tumor
$BHVNBiohaven Ltd.
0 catalysts
Phase 2
BI-1206
B-Cell Non-Hodgkin Lymphoma
BioInvent International AB
0 catalysts
Phase 2
BI-1808
Mycosis Fungoides
BioInvent International AB
0 catalysts
Phase 2
BI-1819479
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
BI-836858
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
BIO-106
Solid Tumor
BiOneCure Therapeutics Inc
0 catalysts
Phase 2
BLB-101
Coronavirus Disease 2019 (COVID-19)
Blue Lake Biotechnology Inc
0 catalysts
Phase 2
BLB-201
Respiratory Syncytial Virus (RSV) Infections
Blue Lake Biotechnology Inc
0 catalysts
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
0 catalysts
Phase 2
BMND-08
Alzheimer's Disease
Biomind Labs Inc
0 catalysts
Phase 2
BMS-986446
Alzheimer's Disease
Bristol-Myers Squibb Co
0 catalysts
Phase 2
BMX-001
High-Grade Glioma
Biomimetix JV LLC
0 catalysts
Phase 2
BNT-111
Metastatic Melanoma
$BNTXBioNTech SE
0 catalysts
Phase 2
BOLD-100
Colorectal Cancer
Bold Therapeutics Inc
0 catalysts
Phase 2
BOXR-1030
Merkel Cell Carcinoma
SOTIO Biotech AS
0 catalysts
Phase 2
BPZE1 vaccine
Pertussis (Whooping Cough)
ILiAD Biotechnologies LLC
0 catalysts
Phase 2
BRC-OA
Osteoarthritis
Britecyte Inc
0 catalysts
Phase 2
BRM-424
Neurotrophic Keratitis
BRIM Biotechnology Inc
0 catalysts
Phase 2
BRTX-100
brtxDISC
Chronic Low Back Pain (CLBP)
$BRTXBioRestorative Therapies, Inc.
0 catalysts
Phase 2
BS-001
Melanoma
Wuhan Binhui Biopharmaceutical Co Ltd
0 catalysts
Phase 2
BS-01
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
0 catalysts
Phase 2
BSI-04702
Solid Tumor
OBI Pharma Inc
0 catalysts
Phase 2
BT-7480
Anal Cancer
$BCYCBICYCLE THERAPEUTICS PLC
0 catalysts
Phase 2
BTM-3566
Burkitt Lymphoma
Bantam Pharmaceutical LLC
0 catalysts
Phase 2
BTXA-51
Refractory Acute Myeloid Leukemia
Edgewood Oncology Inc
0 catalysts
Phase 2
BW-00112
Mixed Dyslipidemia
Shanghai Argo Pharmaceutical Co Ltd
0 catalysts
Phase 2
BX-1000
Anesthetic Effect
Baudax Bio Inc
0 catalysts